Fulvestrant 25021-0471
Product NDC
25021-0471- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Solution
- Route
- Intramuscular
- Product Type
- Human Prescription Drug
- Marketing Start
- April 15, 2026
- Listing Expires
- December 31, 2027
- Application
- ANDA211422
Need to source Fulvestrant? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fulvestrant | 50 mg/mL |
Drug Class
Estrogen Receptor Antagonist [EPC]Estrogen Receptor Antagonist [EPC]Estrogen Receptor Antagonists [MoA]
Packaging Options(1)
2 SYRINGE in 1 CARTON (25021-471-66) / 5 mL in 1 SYRINGE